H. Langecker

534 total citations
37 papers, 179 citations indexed

About

H. Langecker is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry. According to data from OpenAlex, H. Langecker has authored 37 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Clinical Biochemistry. Recurrent topics in H. Langecker's work include Metabolism and Genetic Disorders (7 papers), Hormonal and reproductive studies (6 papers) and Steroid Chemistry and Biochemistry (5 papers). H. Langecker is often cited by papers focused on Metabolism and Genetic Disorders (7 papers), Hormonal and reproductive studies (6 papers) and Steroid Chemistry and Biochemistry (5 papers). H. Langecker collaborates with scholars based in Germany. H. Langecker's co-authors include K. Junkmann, H. Witzgall, Martin Kramer, K. Ibe, G Neuhaus, Gerald S. Hecht, Johannes Willenbrink, Michael Kessel, Stefan Wirtz and Mark S. Kramer and has published in prestigious journals such as European Journal of Endocrinology, Journal of Molecular Medicine and Archives of Toxicology.

In The Last Decade

H. Langecker

29 papers receiving 112 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Langecker Germany	8	28	27	25	22	20	37	179
R. B. Hunter United Kingdom	12	24 0.9×	23 0.9×	32 1.3×	38 1.7×	15 0.8×	24	274
Gerhard Boost United States	7	16 0.6×	19 0.7×	26 1.0×	11 0.5×	34 1.7×	10	353
M. L. Tainter United States	8	33 1.2×	25 0.9×	16 0.6×	15 0.7×	4 0.2×	22	203
Davidson Cs	9	18 0.6×	29 1.1×	38 1.5×	23 1.0×	8 0.4×	21	253
Richard W. Lippman United States	9	29 1.0×	28 1.0×	27 1.1×	11 0.5×	4 0.2×	24	234
G Neuhaus Germany	9	66 2.4×	47 1.7×	32 1.3×	28 1.3×	7 0.3×	47	280
Stanley Levey United States	10	42 1.5×	93 3.4×	33 1.3×	22 1.0×	10 0.5×	24	307
Opie Lh South Africa	9	23 0.8×	25 0.9×	59 2.4×	27 1.2×	14 0.7×	16	289
Herman Siplet United States	9	17 0.6×	55 2.0×	57 2.3×	26 1.2×	56 2.8×	16	265
E. M. K. Geiling United States	9	25 0.9×	10 0.4×	87 3.5×	11 0.5×	10 0.5×	20	270

Countries citing papers authored by H. Langecker

Since Specialization

Citations

This map shows the geographic impact of H. Langecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Langecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Langecker more than expected).

Fields of papers citing papers by H. Langecker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Langecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Langecker. The network helps show where H. Langecker may publish in the future.

Co-authorship network of co-authors of H. Langecker

This figure shows the co-authorship network connecting the top 25 collaborators of H. Langecker. A scholar is included among the top collaborators of H. Langecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Langecker. H. Langecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Langecker, H.. (1969). [Sex differences of enzyme activities in different organs].. PubMed. 19(11). 1769–77. 2 indexed citations

Langecker, H., et al.. (1964). Diglycols�ure-di-(3-carboxy-2,4,6-trijodanilid) (Ioglycamid), ein Kontrastmittel f�r intraven�se Cholangiographie. Naunyn-Schmiedeberg s Archives of Pharmacology. 247(5). 493–508. 8 indexed citations

Langecker, H., et al.. (1962). [Biological effects of 1-methyl-delta1-androsten-17beta-ol-3-one 17-acetate and 17-enanthate (methenolone acetate and methenolone enanthate): growth stimulation, composition of animal body and enzyme metabolism].. PubMed. 12. 218–23. 1 indexed citations

Langecker, H.. (1961). [The metabolite in the human urine after the administration of 17 alpha-ethynyl-19-nortestosterone (norethisterone)].. PubMed. 37. 14–8. 16 indexed citations

Hecht, Gerald S., et al.. (1961). [Pharmacology of 2-sulfanilamido-5-methoxypyrimidine].. PubMed. 11. 695–700. 5 indexed citations

Langecker, H.. (1959). Abspaltung von Acetylen und Bildung von 17-Ketosteroiden aus 17?-�thinyl-nortestosteron und 17?-�thinyl-3,17?-�stradiol durch Einwirkung von Alkali. Die Naturwissenschaften. 46(21). 601–601. 10 indexed citations

Langecker, H., et al.. (1959). ?-(3-Dimethylamino-methylenamino-2,4,6-trijodphenyl)-propions�ure als Gallekontrastmittel. Naunyn-Schmiedeberg s Archives of Pharmacology. 237(2). 186–93. 8 indexed citations

Langecker, H., et al.. (1957). Der Abbau von ?-Phenylpropylalkohol im Organismus von Kaninchen, Hund und Mensch. Naunyn-Schmiedeberg s Archives of Pharmacology. 231(1). 91–5. 1 indexed citations

Busch, Elmar & H. Langecker. (1957). Die chemischen und pharmakologischen Eigenschaften von 7-(?-Isopropylamino-propyl)-theophyllin. Naunyn-Schmiedeberg s Archives of Pharmacology. 230(2). 194–204. 1 indexed citations

10.

Knopp, Jennifer L., et al.. (1956). CHORIONEPITHELIOM BEIM MANNE. European Journal of Endocrinology. 21(3). 289–298. 4 indexed citations

11.

Langecker, H., et al.. (1955). 1-Phenyl-propanol als Cholereticum. Naunyn-Schmiedeberg s Archives of Pharmacology. 225(4). 303–8. 1 indexed citations

12.

Langecker, H.. (1954). Die Verteilung von Hexamethylentetramin auf die Phasen des Blutes, Liquor, Kammerwasser und Pericardfl�ssigkeit beim nierenlosen Hund. Naunyn-Schmiedeberg s Archives of Pharmacology. 221(2). 166–70. 2 indexed citations

13.

Langecker, H., et al.. (1954). 3,5-Diacetylamino-2,4,6-trijodbenzoes�ure als R�ntgenkontrastmittel. Naunyn-Schmiedeberg s Archives of Pharmacology. 222(6). 584–90. 25 indexed citations

14.

Langecker, H., et al.. (1953). 2,4,6-Trijod-3-acetaminobenzoes�ure-Abk�mmlinge als Kontrastmittel. Naunyn-Schmiedeberg s Archives of Pharmacology. 220(3). 195–206. 27 indexed citations

15.

Langecker, H.. (1953). Die Verteilung von Sulfanils�ure und Sulfonamiden beim nierenlosen Hund. Naunyn-Schmiedeberg s Archives of Pharmacology. 218(4). 278–85. 2 indexed citations

16.

Langecker, H.. (1952). Die Ausscheidung von 17-Ketosteroiden bei der Ratte. Naunyn-Schmiedeberg s Archives of Pharmacology. 214(5). 490–6. 1 indexed citations

17.

Langecker, H.. (1952). Die myotrope Wirkung der Nebennieren-Androgene. PubMed. 215(1-2). 25–28. 1 indexed citations

18.

Langecker, H.. (1952). Eine Vereinfachung der Corticoidbestimmung im Harn. Journal of Molecular Medicine. 30(37-38). 906–906. 1 indexed citations

19.

Langecker, H.. (1952). Ein Beitrag zur Bestimmung der Hyalurons�ure in Organen. Journal of Molecular Medicine. 30(9-10). 222–223. 2 indexed citations

20.

Langecker, H.. (1951). [Arterenol and adrenalin].. PubMed. 6(28). 654–60. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact